2017

Peer Reviewed Publications in Print or Other Media

Day TA*, Layer JV*, Cleary JP*, Guha S*, Stevenson KE, Tivey T*, Kim S*, Schinzel AC, Izzo F, Doench J, Root DE, Hahn WC, Price BD, Weinstock DM.  PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.  Nature Communications [online 4/27/17].

https://www.nature.com/articles/ncomms15110

Ajore R, Raiser D, McConkey M, Joud M, Boidol B, Mar B, Saksena G, Weinstock DM, Armstrong S, Ellis SR, Ebert BL, Nilsson B.  Deletion of ribosomal protein genes is a common vulnerability in human cancer, particularly in concert with TP53 mutation.  EMBO Mol Med 2017 [online 3/6/17].

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376749/

Akahane K, Li Z, Etchin J, Berezovskaya A, Gjini E, Masse CE, Miao W, Rocnik J, Kapeller R, Greenwoods JR, Tiv H, Sanda T, Weinstock DM, Look AT.  Anti-leukemic Activity of the TYK2 selective inhibitor NDI-031301 in T-cell Acute Lymphoblastic Leukemia.  Brit J Haematology 2017 [online 3/14/17]

http://onlinelibrary.wiley.com.ezp-prod1.hul.harvard.edu/doi/10.1111/bjh.14563/full

Pikman Y, Alexe G, Roti G, Conway AS, Furman A, Lee AS, Place AE, Kim S, Saran C, Modiste R, Weinstock DM, Harris M, Kung AL, Silverman LB, Stegmaier K. Synergistic drug combinations with a CDK4/6 inhibitor in T-cell acute lymphoblastic leukemia.  Clin Cancer Res 2017;23(4):1012-24

http://clincancerres.aacrjournals.org/content/early/2016/11/09/1078-0432.CCR-15-2869

Herrera AF, Mei M, Low L, Kim HT, Griffin GK, Song JY, Merryman RW, Bedell V, Pak C, Sun H, Paris T, Stiller T, Brown JR, Budde LE, Chan WC, Chen r, Davids MS, Freedman AS, Fisher DC, Jacobsen ED, Jacobson CA*, LaCasce A, Murata-Collins J, Nademanee AP, Palmer JM, Pihan GA, Pillai R, Popplewell L, Siddizi T, Sohani AR, Zain J, Rosen ST, Kwak L W, Weinstock DM, Forman SJ, Weisenburger DD, Kim Y, Rodig SJ, Krishnan A, Armand P. Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.  J Clin Onc 2017;35(1):24-31

http://ascopubs.org/doi/abs/10.1200/JCO.2016.68.2740

Dunford A^, Weinstock DM^, Savova V, Schumacher SE, Cleary JP*, Yoda A*, Sullivan TJ, Gimelbrant AA, Beroukhim R, Lawrence MS^, Getz G^, Lane AA^*. Escape from X-Inactivation Tumor Suppressor (EXITS) genes contribute to cancer sex bias. ^equal contribution Nature Genetics 2017;49:10-16.

http://www.nature.com/ng/journal/v49/n1/full/ng.3726.html

Other Peer-Reviewed Publications

Meehan TF, Conte N, Goldstein TC, Inghirami G, Murakami MA*, Brabetz S, Gu Z, Wiser JA, Dunn P, Begley DA, Krupke DM, Bertotti A, Bruna A, Brush M, Byrne AT, Caldas C, Christie AL, Clark D, Dowst H, Dry JR, Doroshow J, Duchamp O, Evrard YA, Ferretti S, Frese KK, Goodwin NC, Greenawalt DM, Haendel MA, Hermans E, Houghton PJ, Jonkers J, Kemper K, Khor TO, Lewis MT, Lloyd KK, Mason JC, Medico E, Neuhauser SB, Olson JM, Peeper DS, Rueda OM, Seong JK, Trusolino L, Vinolo E, Wechsler-Reya RJ, Weinstock DM, Welm A, Weroha SJ, Amant F, Pfister SM, Kool M, Parkinson H, Butte AJ, Bult CJ. PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.  Cancer Research [in press].

Giwa S, Lewis J, Langer R, Church GM, Sachs D, Markmann J, Boyden E, Lee A, Alvarez L, Elliott G, Weinstock DM, Acker J, Pomahac B, Uygun MK, Eidbo E, Schmalz B, Tocchio A, Weegman B, Fahy G, Rubinsky B, Bischof J, Elliott J, Brandacher G, Storey K, Nelson D, Woodruff T, Demirci U, Brockbank K, Woods E, Ben R, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz D, Taylor MJ, Toner M.  The Promise of Organ and Tissue Preservation to Transform Medicine.  Nature Biotechnology [in press].

Reviews, Chapters, Monographs and Editorials

Yoshida N, Weinstock DM.  It takes a village to unmask HSTL.  Cancer Disc 2017;7:352-3.

http://cancerdiscovery.aacrjournals.org/content/7/4/352.long